Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition

Florencia P. Madorsky Rowdo(Cornell University), Jos� Mordoh(Fundación Instituto Leloir)

International Journal of Oncology

March 30, 2020

10.3892/ijo.2020.5031

Cited by 29

Related Papers

Gut bacteria–derived serotonin promotes immune tolerance in early life

|Science Immunology|2024|84

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection

|Gut Microbes|2022|55

The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution

|Nature|2024|51

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

|Cancer Research|2025|12

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells

|Oncology Reports|2017|7